Latest Breaking News On - Virtual biopharma companies - Page 1 : comparemela.com

Marketresearch.biz reports that the global small molecule innovator CDMO market revenue is expected to increase to USD 84.7 Bn in 2032 from USD 45.4 Bn in 2022, and register a revenue CAGR of 6.6% during the forecast period (2023 to 2032).Overview of the Small Molecule Innovator CDMO MarketThe Small Molecule Innovat.

Saudi arabiaNew yorkUnited statesSouth africaLawrence johnAsia pacificContract developmentAlbany molecular research incContract research organizations crosPrudour pvt ltdManufacturing organization marketComplexity of drug developmentLonza groupPiramal pharma solutionsRise of virtual biopharma companiesSiegfried holding